MECP2 and Parkinson disease: They described that overexpression of MeCP2 was able to ameliorate the 6-hydroxydopamine-induced apoptosis of SH-SY5Y cells, suggesting that MeCP2 is a potential therapeutic target for the treatment of PD [25].